Health Blog : FDA Science Under the Microscope: "A Nobel laureate and a former Merck CEO are among the scientists from industry and academia set to review the state of science at the FDA.
In an agency-wide email distributed late last week and obtained by the WSJ’s Anna Wilde Mathews, FDA Commissioner Andrew von Eschenbach wrote that the group will determine “where there are gaps and unnecessary redundancies across the agency’s scientific work.” The outside experts will also evaluate how well the agency’s scientific capabilities are keeping up with emerging fields.
Gail Cassell, Eli Lilly’s vice president for scientific affairs, is chairing the group. In an interview this morning, she gave us a few clues as to what the they’ll be looking at:"
